Video summary

The Real Reason Antidepressants Don't Work for Anxiety (and the solution) - Dr Trevor Bachmeyer

Main summary

Key takeaways

Wellness and Self-Improvement

Core message

The presenter argues that anxiety is mainly a biological/molecular problem (not a character flaw or primarily a “thinking” issue). Therefore, the “solution” is neurobiological reconstruction—repairing dysfunctional threat-processing circuits, restoring inhibitory (GABA) signaling, reducing neuroinflammation, correcting cortisol dysregulation, and improving hippocampal/vagus–prefrontal connectivity—rather than relying on antidepressants (SSRIs/MAOIs) or benzodiazepines alone.

Key wellness/self-care strategies & “solution” framework

1) Reframe anxiety causes (the biological “systems” model)

Anxiety is described as a network involving:

  • Amygdala hyper-reactivity (rapid threat detection)
  • Locus coeruleus norepinephrine overactivity (sustained sympathetic activation)
  • HPA axis / cortisol dysregulation (notably elevated evening cortisol)
  • Reduced GABA braking (downregulated GABA receptors)
  • Neuroinflammation / immune activation (microglia–cytokine feedback loop)
  • Hippocampal dysfunction (reduced contextual memory formation; cortisol neurotoxicity)
  • Reduced prefrontal–amygdala connectivity (weaker top-down inhibition)
  • Lower vagal tone / impaired vagus nerve “reset” function

2) Avoid (or be skeptical of) symptom-only drugs

The presenter claims conventional medications can “miss the point”:

  • SSRIs: “force serotonin” into an already inflamed system
  • Benzodiazepines: “force GABA” into receptors he says are downregulated → risk of dependency/tolerance and difficult discontinuation

He also criticizes therapy-only approaches, while still suggesting therapy may be helpful for some people.

3) “Molecular reconstruction” protocol (foundational nutrients + targeted compounds)

Supplements are emphasized as missing building blocks that allow the brain to rebuild.

Foundational nutrient protocol (building blocks)

  • Magnesium L-threonate: ~2000 mg/day
  • Zinc glycinate: ~30 mg/day
  • Glycine: ~5 g/day
  • Omega-3 (EPA/DHA): ~3–4 g/day
  • Pyridoxal 5-phosphate (B6): ~50 mg/day
  • Methylcobalamin (B12): ~1000–2000 mcg/day (suggests ~1000 mcg/day, “up to 1200”)
  • Methylfolate: ~800 mcg/day (suggests possibly 400–500 if needed)
  • L-theanine: ~200 mg/day
  • Selenium: ~200 mcg/day
  • Taurine: ~3 g/day

Targeted “reconstruction” compounds he highlights

  • Selank (tetrapeptide; “rebuilds brakes”)

    • Claims increased GABA receptor density
    • Claims increased serotonin receptor sensitivity (e.g., 5-HT1A)
    • Claims improvements in dopamine availability (motivation/reward)
    • Claims anti-inflammatory effects (↓ TNF-α, IL-6; ↑ IL-10/TGF-β; reduces oxidative stress)
    • Claims support for BDNF and neurogenesis
    • Claims improved vagal tone/HRV (parasympathetic reset)

  • Aniracetam (racetam; “optimizes signaling”)

    • Claims improved membrane fluidity and AMPA receptor function
    • Claims enhanced long-term potentiation (hippocampus/learning)
    • Framed as balancing excitatory/inhibitory transmission rather than “turning off” threat detection

  • BPC-157 (peptide; “structural repair / vagus / BBB”)

    • Claims vagus nerve regeneration and improved parasympathetic signaling
    • Claims blood–brain barrier (BBB) integrity repair (tight junction proteins)
    • Claims inflammation resolution via anti-inflammatory cytokine shifts (e.g., ↑ IL-10, ↓ NF-κB-related pathways)
    • Claims support for GABA-A receptor stability/trafficking
    • Claims support for hippocampal neurogenesis (dentate gyrus)

4) Synergy emphasis (why a combined approach)

He frames results as better with stacking:

  • Nutrients provide substrate/building blocks
  • Selank rebuilds inhibitory control + reduces inflammation
  • Aniracetam supports learning-related synaptic plasticity
  • BPC-157 repairs structural/nerve/barrier components and further supports neurogenesis/inflammation resolution

5) Implementation guidance (timing + basic dosing)

He presents dosing ranges as his protocol (not medical directives).

  • Aniracetam: up to 1500 mg/day total, split 750 mg twice daily with meals
    • Taken with fat for absorption
    • Onset may be noticeable quickly; “about 2 weeks” for deeper effect
  • BPC-157: ~500 mcg to 1 mg/day
    • Suggested cycling: 12 weeks on, 2 weeks off, or “indefinitely”
    • Suggests downregulation is less likely at 500 mcg/day
  • Nutrients: dosed at the daily targets listed above

6) Productivity/product/engagement tips (non-clinical)

The video also includes program-style messaging:

  • Claims it takes about 1 year of protocol work to change physiology
  • He runs:
    • 1 live Q&A call (Monday)
    • another call (Saturday)
  • Criticizes “Insta experts” and emphasizes accuracy in dosing/protocol direction over generic advice

Key themes to extract (one-line takeaway)

Treat anxiety as broken neurobiology → rebuild the system using nutrient cofactors + targeted compounds aimed at GABA recovery, inflammation reduction, hippocampal rewiring, cortisol normalization, and vagal reset.

Presenters / sources mentioned

  • Presenter: Dr Trevor Bachmeyer
  • Program/website referenced: unlockthecard.com
  • Compounds/brands discussed: Selank; aniracetam; BPC-157; magnesium L-threonate; zinc glycinate; glycine; omega-3 (EPA/DHA); pyridoxal 5-phosphate (B6); methylcobalamin (B12); methylfolate; L-theanine; selenium; taurine

Referenced studies/authors/journals (as cited in subtitles)

  • Lanzi & JAMA Psychiatry (2011)
  • McHugh & New England Journal of Medicine (2004) (allostatic load)
  • Klumpers in Nature Neuroscience (2013)
  • Woon & Hedges in NeuroImage (2014) (hippocampal volume)
  • Etkin & Wager in Neuro Science and Biobehavioral Reviews (2011)
  • Kozlovskaya in Biological Psychiatry (2014) (Selank/GABA receptors)
  • Kar Koba in Journal of Psychopharmacology (2011) (Selank/5-HT1A binding)
  • Kozlovskaya (2012) (Selank/dopamine availability)
  • Komensev in Bulletin of Experimental Biology and Medicine (2015) (Selank/CSF cytokines)
  • Gusev in Neuroscience and Behavioral Reviews (2012) (Selank/BDNF)
  • Gualtieri in Psychopharmacology (2016) (Selank/vagal tone/HRV)
  • Slutsky in Neuron (2010) (magnesium L-threonate / synaptic density; NMDA function)
  • Swartzwelder in Progress in Neuropsychopharmacology and Biological Psychiatry (2011) (zinc/GABA)
  • Nutrients (2014) (zinc/TH17 pro-inflammatory differentiation)
  • Benigni et al. in Amino Acids (2015) (glycine/anxiety & sleep)
  • Chulalongkorn et al. in Journal of Clinical Psychiatry (2015) (omega-3 meta-analysis)
  • Zanarini in Psychiatry Research (2011) (omega-3 vs fluoxetine)
  • Bottiglieri in Journal of Psychiatric Research (2017) (homocysteine/methylation/anxiety)
  • Almeida in Molecular Psychiatry (2016) (B-vitamins/homocysteine/anxiety)
  • Novare / Biological Psychiatry (2008) (L-theanine/alpha waves)
  • Lopresti in Psychiatric Research (2013) (selenium deficiency/anxiety)
  • Wu in Amino Acids (2014) (taurine/inhibitory tone)
  • Gaspari in Pharmacology, Biochemistry and Behavior (1991) (aniracetam/glucose metabolism)
  • Winblad in CNS Drug Reviews (2003) (aniracetam neurotransmission)
  • Ahmed in Neuroscience Letters (2004) (aniracetam/AMPA receptor mobility)
  • Malik & Sadaie in Drugs (2002) (aniracetam/LTP)
  • Gasparini in Neuroscience (2001) (aniracetam neurotransmitter release probability)
  • SeaWorth in Journal of Psychology / Journal of Physiology and Pharmacology (2018) (BPC-157 vagus regeneration)
  • SeaWorth in Brain Research (2016) (BPC-157 BBB integrity/tight junctions)
  • Gem brecken life sciences (2019) (BPC-157 microglia activation)
  • Zivanovic in Neuroscience and Behavioral Biobehavioral Reviews (2017) (BPC-157 GABA-A receptor stability/trafficking)
  • Kozlovskaya (2012) (BPC-157 neurogenesis)
  • SeaWorth in Regulatory Peptides (2016) (BPC-157 HPA axis/cortisol)
  • International Journal of Molecular Sciences (2018) (review on combination vs monotherapy)

Additional general claims mentioned: FDA, Big Pharma, Tony Robbins (cited as an example of an alternative psychologist claim).

Original video